In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

The workshop will train healthcare providers on the HEARTS clinical pathway, including guidance on medication ... “It’s a ...

Liddle syndrome is an autosomal dominant disorder caused by hyperactivity of the amiloride-sensitive sodium channel (ENaC) of the principal cell of the cortical collecting tubule. In 1963, Liddle ...

Combining radium-223 with enzalutamide offered a survival benefit in metastatic castration-resistant prostate cancer, but experts questioned its relevance in a shifting treatment landscape.

Corcept is a profitable biotech company with significant potential for growth, focusing on treating Cushing's Syndrome and ...

Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Purple Biotech (PPBT – Research Report). The associated price ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

Leveraging genetics, biomarkers and predictive sciences, we target key pathways involved in the initiation and ... cerebrovascular disease, and uncontrolled hypertension with a history of Mobitz type ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term overall survival (OS) data ...

Visual disturbances which are associated with neurological disorders and strokes are numerous and may have severe and diverse ...

In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have ...